COMPLETE GENOMICS INC Net Change in Cash
COMPLETE GENOMICS INC reported Net Change in Cash of -$42.36 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-09.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2012-11-09
- COMPLETE GENOMICS INC cash and cash equivalents, period increase (decrease) for the quarter ending 2012-09-30 was -$4.54M.
- COMPLETE GENOMICS INC cash and cash equivalents, period increase (decrease) for the quarter ending 2012-06-30 was -$7.86M, a 156.29% decline year-over-year.
- COMPLETE GENOMICS INC cash and cash equivalents, period increase (decrease) for the quarter ending 2012-03-31 was -$29.95M.
- COMPLETE GENOMICS INC cash and cash equivalents, period increase (decrease) for the quarter ending 2011-12-31 was $12.16M, a 79.18% decline year-over-year.
- COMPLETE GENOMICS INC cash and cash equivalents, period increase (decrease) for fiscal 2011 was $8.16M, a 86.66% decline from fiscal 2010.
- COMPLETE GENOMICS INC cash and cash equivalents, period increase (decrease) for fiscal 2010 was $61.15M, a 3772.89% increase from fiscal 2009.
- COMPLETE GENOMICS INC cash and cash equivalents, period increase (decrease) for fiscal 2009 was $1.58M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2012-09-30 | -$4.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$12.40M derived: sum of 2 quarters · filed 2012-11-09 | -$42.36M 10-Q · filed 2012-11-09 | -$30.20M derived: sum of 4 quarters · filed 2012-11-09 |
| 2012-06-30 | -$7.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$37.82M 10-Q · filed 2012-08-09 | -$25.65M derived: sum of 3 quarters · filed 2012-08-09 | -$43.50M derived: sum of 4 quarters · filed 2012-11-09 |
| 2012-03-31 | -$29.95M 10-Q · filed 2012-05-09 | -$17.79M derived: sum of 2 quarters · filed 2012-05-09 | -$35.64M derived: sum of 3 quarters · filed 2012-11-09 | -$21.67M derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-12-31 | $12.16M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | -$5.68M derived: sum of 2 quarters · filed 2012-11-09 | $8.28M derived: sum of 3 quarters · filed 2012-11-09 | $8.16M 10-K · filed 2012-03-09 |
| 2011-09-30 | -$17.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$3.88M derived: sum of 2 quarters · filed 2012-11-09 | -$4.01M 10-Q · filed 2012-11-09 | $54.41M derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-06-30 | $13.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $13.84M 10-Q · filed 2012-08-09 | $72.26M derived: sum of 3 quarters · filed 2012-08-09 | $74.78M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-03-31 | -$127.00K 10-Q · filed 2012-05-09 | $58.30M derived: sum of 2 quarters · filed 2012-05-09 | $60.82M derived: sum of 3 quarters · filed 2012-05-09 | |
| 2010-12-31 | $58.42M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $60.95M derived: sum of 2 quarters · filed 2012-03-09 | $61.15M 10-K · filed 2012-03-09 | |
| 2010-09-30 | $2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $2.73M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $207.00K 10-Q · filed 2011-08-15 | |||
| 2009-12-31 | $1.58M 10-K · filed 2012-03-09 |